細胞激素市場：按類型、按治療應用、按最終用戶、按地區

細胞激素市場預計到2024年將達到908.4億美元，預計到2031年將達到1,613.8億美元，2024年至2031年的複合年成長率為8.6%。

圖：2024 年按地區分類的細胞激素市場佔有率(%)

細胞激素是細胞訊號蛋白，對於控制和調節免疫和發炎反應非常重要。細胞激素可作為免疫細胞之間的橋樑，介導或控制免疫和發炎，作為免疫反應的一部分。隨著慢性發炎疾病、癌症和感染疾病的日益流行，用於診斷目的的細胞激素測定的需求顯著成長。重組 DNA 技術的進步使得不同類型的細胞激素的大規模生產成為可能，促進了市場的成長。然而，在預測期內，與細胞激素研究相關的高成本可能會在一定程度上限制市場擴張。

市場動態：

慢性和危及生命的疾病盛行率的增加是推動細胞激素市場成長的主要因素。主要市場促進因素包括全球癌症和感染疾病的增加。 2020年，全球癌症患者數將達1,930萬，癌症死亡人數將達1,000萬人。同樣，COVID-19 和結核病等感染疾病正在增加對新診斷和治療方法（包括細胞激素分析）的需求。此外，政府和私人組織增加細胞激素研究資金的舉措正在為市場參與者創造利潤豐厚的機會。然而，細胞激素生產技術的高生產成本和技術限制繼續阻礙市場潛力。細胞激素的保存期限短和穩定性差也為更廣泛的商業化帶來了挑戰。

本研究的主要特點

該報告詳細分析了全球細胞激素市場，並提供了以 2023 年為基準年的預測期（2024-2031）的市場規模（十億美元）和年複合成長率（CAGR%）。

它還揭示了各個細分市場的潛在商機，並說明了該市場中有吸引力的投資提案的矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

根據公司亮點、產品系列、主要亮點、績效和策略等參數對全球細胞激素市場的主要企業進行了分析。

本研究涵蓋的主要企業包括 Abbott、AB Sciex、Agilent Technologies Inc.、bioMerieux SA、Bio-Rad Laboratories Inc.、DiaSorin SpA、F. Hoffmann-La Roche Ltd.、Quest Diagnostics Inc.、Danaher，其中包括 DiarinSo SpA 、免疫診斷系統和Fujirebio, Inc.

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、產品創新、市場擴張和行銷策略做出明智的決策。

全球細胞激素市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

相關人員可以透過分析全球細胞激素市場時所使用的各種策略矩陣來促進他們的決策。

目錄

第1章 分析目的與前提

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章市場動態、法規與趨勢分析

• 市場動態
• 影響分析
• 主要亮點
• 監管場景
• 產品發布/核准
• PEST分析
• 波特的分析
• 企業合併(M&A) 場景

第 4 章細胞激素市場：按類型分類，2019-2031 年（十億美元）

• 腫瘤壞死因子
• 白細胞介素-II
• 干擾素-IFN
• 表皮生長因子（EGF）
• 其他

第5章細胞激素市場：依治療應用分類，2019-2031（十億美元）

• 癌症
• 氣喘
• 關節炎
• 血液學
• 其他

第6章細胞激素市場：以最終用戶分類，2019-2031 年（十億美元）

• 醫院
• 實驗室
• 其他

第7章細胞激素市場：依地區分類，2019-2031（十億美元）

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第8章 競爭格局

• Abbott
• AB Sciex
• Agilent Technologies Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin SpA
• F.Hoffmann-La Roche Ltd.
• Quest Diagnostics Inc
• Danaher
• DiaSorin SpA
• Immunodiagnostic Systems
• Fujirebio, Inc.

第9章 分析師建議

• 《命運之輪》
• 分析師觀點
• Coherent Opportunity Map (COM)

第10章 參考文獻與調查方法

• 參考
• 分析方法
• 關於相干市場洞察

The cytokine market is estimated to be valued at USD 90.84 Bn in 2024 and is expected to reach USD 161.38 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Figure. Cytokine Market Share (%), By Region, 2024

Cytokines are cell-signalling proteins that are crucial for controlling and regulating immune responses and inflammatory reactions. They act as the bridge intermediaries between immune cells and mediate or regulate immunity and inflammation as part of immune response. With the increasing prevalence of chronic inflammatory diseases, cancer, and infectious diseases, the demand for cytokine assays for diagnostic purposes has been growing significantly. Advancements in recombinant DNA technology have enabled mass production of different types of cytokines, thus aiding market growth. However, high costs associated with cytokine research may restrain market expansion to some extent over the forecast period.

Market Dynamics:

Increasing incidence of chronic and life-threatening diseases is a key factor driving the cytokine market growth. Some of the major market drivers include rising cases of cancers and infectious diseases globally. , the global cancer burden has risen to 19.3 million cases and 10 million cancer deaths in 2020. Similarly, infectious diseases like COVID-19, tuberculosis, etc. have surged the need for new diagnostic and therapeutic approaches including cytokine profiling. Further, initiatives by governments and private organizations to increase funding for cytokine research present lucrative opportunities for market players. However, high production costs and technical limitations of cytokine production techniques continue to hamper market potential. Short shelf-life and poor stability of cytokines also challenge wider commercialization.

Key Features of the Study:

This report provides in-depth analysis of the global cytokine market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global cytokine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc, Danaher, DiaSorin S.p.A, Immunodiagnostic Systems, Fujirebio, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global cytokine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cytokine market

Market Segmentation

• Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Tumor Necrosis Factor-TNF
  • Interleukins-II
  • Interferons-IFN
  • Epidermal Growth Factor-EGF
  • Others
• Therapeutic Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Cancer
  • Asthma
  • Arthritis
  • Hematology
  • Others
• End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospitals
  • Research laboratories
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott
  • AB Sciex
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A.
  • Hoffmann-La Roche Ltd.
  • Quest Diagnostics Inc
  • Danaher
  • DiaSorin S.p.A
  • Immunodiagnostic Systems
  • Fujirebio, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Cytokine Market, By Type
  • Cytokine Market, By Therapeutic Application
  • Cytokine Market, By End User
  • Cytokine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Cytokine Market, By Type, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Tumor Necrosis Factor-TNF
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Interleukins-II
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Interferons-IFN
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Epidermal Growth Factor-EGF
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Cytokine Market, By Therapeutic Application, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Asthma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Arthritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hematology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Cytokine Market, By End User, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Research laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Cytokine Market, By Region, 2019 - 2031, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country/Region 2019 - 2031, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AB Sciex
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• bioMerieux SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DiaSorin S.p.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F.Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quest Diagnostics Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DiaSorin S.p.A
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Immunodiagnostic Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fujirebio, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us